Literature DB >> 36243769

Interactive relationships of Type 2 diabetes and bipolar disorder with cognition: evidence of putative premature cognitive ageing in the UK Biobank Cohort.

Elysha Ringin1, David W Dunstan2,3, Roger S McIntyre4, Michael Berk5,6,7, Neville Owen2,8, Susan L Rossell9,10, Tamsyn E Van Rheenen11,12.   

Abstract

Type 2 diabetes (T2D) is disproportionately prevalent in bipolar disorder (BD) and is associated with cognitive deficits in psychiatrically healthy cohorts. Whether there is an interaction effect between T2D and BD on cognition remains unclear. Using the UK Biobank, we explored interactions between T2D, BD and cognition during mid and later life; and examined age-related cognitive performance effects in BD as a function of T2D. Data were available for 1511 participants with BD (85 T2D), and 81,162 psychiatrically healthy comparisons (HC) (3430 T2D). BD and T2D status were determined by validated measures created specifically for the UK Biobank. Diagnostic and age-related associations between T2D status and cognition were tested using analyses of covariance or logistic regression. There was a negative association of T2D with visuospatial memory that was specific to BD. Processing speed and prospective memory performance were negatively associated with T2D, irrespective of BD diagnosis. Cognitive deficits were evident in BD patients with T2D compared to those without, with scores either remaining the same (processing speed) or improving (visuospatial memory) as a function of participant age. In contrast, cognitive performance in BD patients without T2D was worse as participant age increased, although the age-related trajectory remained broadly equivalent to the HC group. BD and T2D associated with cognitive performance deficits across the mid-life period; indicating comorbid T2D as a potential risk factor for cognitive dysfunction in BD. In comparison to BD participants without T2D and HCs, age-independent cognitive impairments in BD participants with comorbid T2D suggest a potential premature deterioration of cognitive functioning compared to what would normally be expected.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36243769     DOI: 10.1038/s41386-022-01471-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  53 in total

Review 1.  A Systematic Review of Studies Reporting Data-Driven Cognitive Subtypes across the Psychosis Spectrum.

Authors:  Melissa J Green; Leah Girshkin; Kyle Kremerskothen; Oliver Watkeys; Yann Quidé
Journal:  Neuropsychol Rev       Date:  2019-12-18       Impact factor: 7.444

2.  Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.

Authors:  K E Burdick; M Russo; S Frangou; K Mahon; R J Braga; M Shanahan; A K Malhotra
Journal:  Psychol Med       Date:  2014-03-11       Impact factor: 7.723

3.  Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.

Authors:  T E Van Rheenen; K E Lewandowski; E J Tan; L H Ospina; D Ongur; E Neill; C Gurvich; C Pantelis; A K Malhotra; S L Rossell; K E Burdick
Journal:  Psychol Med       Date:  2017-02-28       Impact factor: 7.723

Review 4.  Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence.

Authors:  Tamsyn E Van Rheenen; Kathryn E Lewandowski; Isabelle E Bauer; Flavio Kapczinski; Kamilla Miskowiak; Katherine E Burdick; Vicent Balanzá-Martínez
Journal:  Bipolar Disord       Date:  2019-08-29       Impact factor: 6.744

5.  Cognitive validation of cross-diagnostic cognitive subgroups on the schizophrenia-bipolar spectrum.

Authors:  James A Karantonis; Susan L Rossell; Sean P Carruthers; Philip Sumner; Matthew Hughes; Melissa J Green; Christos Pantelis; Katherine E Burdick; Vanessa Cropley; Tamsyn E Van Rheenen
Journal:  J Affect Disord       Date:  2020-01-25       Impact factor: 4.839

Review 6.  Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Authors:  M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi
Journal:  Neurosci Biobehav Rev       Date:  2010-10-08       Impact factor: 8.989

7.  Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up.

Authors:  K E Burdick; J F Goldberg; M Harrow
Journal:  Acta Psychiatr Scand       Date:  2010-12       Impact factor: 6.392

Review 8.  The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.

Authors:  Lucas Bortolotto Rizzo; Leonardo Gazzi Costa; Rodrigo B Mansur; Walter Swardfager; Síntia Iole Belangero; Rodrigo Grassi-Oliveira; Roger S McIntyre; Moisés E Bauer; Elisa Brietzke
Journal:  Neurosci Biobehav Rev       Date:  2014-02-15       Impact factor: 8.989

9.  Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.

Authors:  Casey Crump; Kristina Sundquist; Marilyn A Winkleby; Jan Sundquist
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

10.  A Systematic Review of Cognition-Brain Morphology Relationships on the Schizophrenia-Bipolar Disorder Spectrum.

Authors:  James A Karantonis; Sean P Carruthers; Susan L Rossell; Christos Pantelis; Matthew Hughes; Cassandra Wannan; Vanessa Cropley; Tamsyn E Van Rheenen
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.